Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

Circulatory System Devices Panel – April 4, 2000

A meeting of the Circulatory System Devices Panel was held on April 4, 2000.

FDA Staff made a brief presentation on the Least Burdensome provisions of the FDA Modernization Act of 1997.

Subsequently, the committee provided input to the agency regarding the design of clinical trials for the following: 1) devices using spinal cord stimulation in the treatment of angina pectoris; 2) rate-responsive pacemakers, specifically the evaluation of rate-adaptive features; and 3) devices used in the treatment of atrial fibrillation.

Contact: John Stuhlmuller, M.D., at 301-443-8243, x157

Transcripts of this meeting may be purchased from Miller Reporting, 507 C St., N.E., Washington, DC 20002, 202-546-6666 or 1-800-833-7947 (FAX: 202-546-6666) and from the Food and Drug Administration, Freedom of Information Staff (HFI-35), 5600 Fishers Lane, Rockville, MD 20857, 301-443-1726.

Page Last Updated: 08/05/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English